Navigation Links
Palatin Technologies, Inc. December 31, 2010 Quarter Results; Teleconference and Webcast to be Held on February 24, 2011
Date:2/18/2011

CRANBURY, N.J., Feb. 18, 2011 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE Amex: PTN) will host a conference call and webcast on February 24, 2011 at 11:00 a.m. Eastern Time to discuss its quarter ended December 31, 2010 financial results and plans for its programs under development.  

Schedule for the Financial Results Press Release, Conference Call / Webcast

  • Q2 Fiscal Year 2011 Conference Call-Live
  • Domestic Dial-In Number

    International Dial-In Number

    Pass code

    2/24/2011 at 11:00 a.m. ET1-888-254-2801

    1-913-981-4905

    2873560


  • Q2 Fiscal Year 2011 Conference Call-Replay
  • Domestic Dial-In Number

    International Dial-In Number

    Pass code

    2/24-3/3/20111-888-203-1112

    1-719-457-0820

    2873560


  • Webcast Live and Replay Access
  • http://www.palatin.com The webcast and replay can be accessed by logging on to the "Investor/Media Center-Webcasts" section of Palatin's website at http://www.palatin.com

    About Palatin Technologies, Inc.Palatin Technologies, Inc. is a biopharmaceutical company dedicated to the development of peptide, peptide mimetic and small molecule agonists with a focus on melanocortin and natriuretic peptide receptor systems. Palatin's strategy is to develop products and then form marketing collaborations with industry leaders in order to maximize their commercial potential.  For additional information regarding Palatin, please visit Palatin Technologies' website at www.palatin.com.


    '/>"/>

    SOURCE Palatin Technologies, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1

    Related biology technology :

    1. Palatin Technologies, Inc. Reports Second Quarter Fiscal Year 2011 Results
    2. Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2011 Results; Teleconference and Webcast to be held on November 16, 2010
    3. Palatin Technologies, Inc. to Report Fiscal Year 2011 First Quarter Results; Teleconference and Webcast to be Held on November 16, 2010
    4. Palatin Announces Strategic Realignment of Operations
    5. Palatin Technologies, Inc. to Raise $2.0 Million Dollars in Registered Direct Offering
    6. Palatin Technologies, Inc. Reports Second Quarter Fiscal Year 2010 Results; Teleconference and Webcast to be held on February 16, 2010
    7. Palatin Technologies, Inc. Issued U.S. Patent for Heart Failure Drug Candidate
    8. Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2010 Results; Teleconference and Webcast to be held on November 16, 2009
    9. Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year End 2009 Results; Teleconference and Webcast to be held on September 8, 2009
    10. Palatin Technologies, Inc. to Report Fourth Quarter and Fiscal Year 2009 Results; Teleconference and Webcast to be held on September 8, 2009
    11. Palatin Technologies to Present at the Rodman & Renshaw 11th Annual Global Investment Conference
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:1/14/2014)... 14, 2014 EquitiesIQ, a leading informational ... ALQA). Alliqua is an emerging biomedical company acquiring, developing, ... care market. , Free report download: http://equitiesiq.com/reports/alliqua/ ... seasoned management team and Board, which launched the company’s ...
    (Date:1/14/2014)... DIEGO and BETHESDA, Md. ... are joining together with two institutes from the National ... reliable tools for bringing safer, more effective treatments to ... the National Center for Advancing Translational Sciences (NCATS) and ...
    (Date:1/14/2014)... In recent years, growing suspicion about the pharmaceutical ... and promotion has led to unprecedented levels of public ... about the insidious impact of commercialization of research, has ... the world’s biggest pharmas for illegal marketing activities, allegations ...
    (Date:1/14/2014)... (PRWEB) January 14, 2014 Global ... developing innovative information technology solutions for patients, physicians, ... care stakeholders, announced today the signing of a ... Food and Drug Administration (FDA). This initiative ...
    Breaking Biology Technology:EquitiesIQ Initiates Coverage of Alliqua, Inc. 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 3Organovo Announces Collaboration with National Institutes of Health 2Organovo Announces Collaboration with National Institutes of Health 3The Sunshine Act: Necessary Regulation or Unnecessary Dysregulation? New Life Science Webinar Hosted by Xtalks and IRB Services 2The Sunshine Act: Necessary Regulation or Unnecessary Dysregulation? New Life Science Webinar Hosted by Xtalks and IRB Services 3Global Record Systems Announces Research Collaboration Agreement with FDA to Create a Novel “Big Data” Paradigm for Collection of Patient Safety and Outcomes Information 2
    ... , , MIGDAL HAEMEK, Israel , Feb. ... for modern medicine, as their origins are unclear and the comprehension ... , Applied Spectral Imaging (ASI) a leading provider of ... European Union (EU) to be one out of nine industry and ...
    ... ... , ... February 16, 2010 -- Akaza Research is pleased to announce its participation in the ... is being held at the Orlando World Center Marriott Resort and is one of ...
    ... ... for comparison, querying, and sharing of NGS runs; free 2-hour seminar, includes lunch and ... ... Sequencing , , ,Learn about sequence data management and the GenomeQuest interactive, web-based tools ...
    Cached Biology Technology:EU Recognizes Importance of ASI's Research on Developing New Smart Imaging Molecular Tools for Combating Neurodegenerative Diseases 2EU Recognizes Importance of ASI's Research on Developing New Smart Imaging Molecular Tools for Combating Neurodegenerative Diseases 3Akaza Research to Present OpenClinica Electronic Data Capture Software at Partnerships in Clinical Trials 2010 2GenomeQuest Announces Boston Seminar: Sequence Data Management for Next Generation Sequencing 2
    (Date:4/16/2014)... Florida State University researchers have identified a new syndrome ... density and muscle mass with obesity. , "It used ... the better your bones would be because the bones ... Stiebeling Professor of Nutrition at Florida State. "But, that,s ...
    (Date:4/16/2014)... known as Kennedy,s disease, spinal and bulbar muscular atrophy (SBMA) ... muscle weakness and atrophy. Researchers have long considered it to ... cells in the spinal cord and brainstem that control muscle ... April 16, 2014 online issue of Neuron , a ...
    (Date:4/16/2014)... do all of our movements, thoughts and feelings ... recent studies have suggested that some of the conversations might ... may be listening in on, or even participating in, some ... astrocytes might only be tuning in part of the time ...
    Breaking Biology News(10 mins):Researchers: Obesity can amplify bone and muscle loss 2Mutant protein in muscle linked to neuromuscular disorder 2Eavesdropping on brain cell chatter 2Eavesdropping on brain cell chatter 3
    ... College of Medicine have discovered how the mutated huntingtin gene ... Huntington,s disease. The report of their findings is available in ... to show that the mutated huntingtin gene activates a particular ... further, to show what effect activation of that enzyme has ...
    ... DC - A protein known to play a role ... have a mixed function in breast cancer development, say ... University Medical Center (GUMC). The findings, presented at ... DC, indicate that the function of this protein, known ...
    ... Sophisticated sensors that measure leaf wetness, soil moisture ... Springbrook World Heritage precinct in south-east Queensland. ... uncover the microclimatic conditions favourable for rapid natural ... of ten sensor nodes, connected wirelessly, has been ...
    Cached Biology News:Huntington's disease deciphered 2Huntington's disease deciphered 3Dual role in breast tissue for a protein involved in leukemia 2Rainforest rehab in every sense 2
    Human Osteocalcin (1-22) mature form. Also reacts with Osteocalcin (1-44) and Osteocalcin (1-49). No reactivity with Bone sialoprotein....
    TGF-beta 1,-2,-3 MAb (Clone 1D11)...
    1/4" to 1/8" Adapter for Reflectance Probe Holder...
    Request Info...
    Biology Products: